Mathias Buttmann

6.1k total citations
50 papers, 1.7k citations indexed

About

Mathias Buttmann is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mathias Buttmann has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Mathias Buttmann's work include Multiple Sclerosis Research Studies (22 papers), Polyomavirus and related diseases (11 papers) and Peripheral Neuropathies and Disorders (8 papers). Mathias Buttmann is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Polyomavirus and related diseases (11 papers) and Peripheral Neuropathies and Disorders (8 papers). Mathias Buttmann collaborates with scholars based in Germany, United States and Switzerland. Mathias Buttmann's co-authors include Peter Rieckmann, Axel Haarmann, Edgar Serfling, Friederike Berberich‐Siebelt, Joseph Claßen, Petra Knaus, Walter Sebald, Franz Grehn, Tobias Meyer‐ter‐Vehn and Elior Peles and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Mathias Buttmann

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathias Buttmann Germany 26 506 492 390 371 346 50 1.7k
H.‐P. Hartung Germany 18 340 0.7× 352 0.7× 630 1.6× 308 0.8× 474 1.4× 62 1.6k
Camelia‐Maria Monoranu Germany 20 402 0.8× 331 0.7× 221 0.6× 149 0.4× 339 1.0× 54 1.4k
Alastair Compston United Kingdom 24 434 0.9× 432 0.9× 607 1.6× 188 0.5× 401 1.2× 74 1.7k
Ian Sutton Australia 20 352 0.7× 542 1.1× 363 0.9× 233 0.6× 814 2.4× 43 2.0k
Peter J. Darlington Canada 18 447 0.9× 753 1.5× 463 1.2× 215 0.6× 146 0.4× 35 1.6k
Tomoko Okamoto Japan 18 636 1.3× 338 0.7× 655 1.7× 162 0.4× 659 1.9× 85 1.9k
Christopher Harp United States 18 380 0.8× 900 1.8× 607 1.6× 184 0.5× 187 0.5× 32 1.8k
Tatsusada Okuno Japan 22 664 1.3× 404 0.8× 508 1.3× 121 0.3× 406 1.2× 77 1.8k
Merja Soilu‐Hänninen Finland 27 345 0.7× 600 1.2× 1.2k 3.2× 339 0.9× 372 1.1× 72 2.2k
Maddalena Ruggieri Italy 21 501 1.0× 228 0.5× 468 1.2× 132 0.4× 382 1.1× 55 1.4k

Countries citing papers authored by Mathias Buttmann

Since Specialization
Citations

This map shows the geographic impact of Mathias Buttmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Buttmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Buttmann more than expected).

Fields of papers citing papers by Mathias Buttmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Buttmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Buttmann. The network helps show where Mathias Buttmann may publish in the future.

Co-authorship network of co-authors of Mathias Buttmann

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Buttmann. A scholar is included among the top collaborators of Mathias Buttmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Buttmann. Mathias Buttmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weber, Martin S., Mathias Buttmann, Sven G. Meuth, et al.. (2022). Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study. Frontiers in Neurology. 13. 863105–863105. 9 indexed citations
3.
4.
Hahn, Stefanie, George Trendelenburg, Madeleine Scharf, et al.. (2017). Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. Journal of Neuroinflammation. 14(1). 123–123. 13 indexed citations
5.
Groh, Janos, Hana Friedman, Nadiya Orel, et al.. (2016). Pathogenicinflammation in the CNS of mice carrying humanPLP1mutations. Human Molecular Genetics. 25(21). ddw296–ddw296. 22 indexed citations
6.
Doppler, Kathrin, Luise Appeltshauser, Carmen Villmann, et al.. (2016). Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain. 139(10). 2617–2630. 139 indexed citations
7.
Halbgebauer, Steffen, André Huss, Mathias Buttmann, et al.. (2016). Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis. Journal of Neurology. 263(5). 954–960. 10 indexed citations
8.
Groh, Janos, David Stadler, Mathias Buttmann, & Rudolf Martini. (2014). Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography. Acta Neuropathologica Communications. 2(1). 54–54. 32 indexed citations
9.
Buttmann, Mathias, Srini V. Kaveri, & Hans‐Peter Hartung. (2013). Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders. Trends in Pharmacological Sciences. 34(8). 445–457. 16 indexed citations
10.
Hartmann, Elena, Ellen Leich, Andreas Rosenwald, et al.. (2012). Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis. PLoS ONE. 7(12). e52208–e52208. 38 indexed citations
11.
Weißbrich, Benedikt, et al.. (2012). Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis. PLoS ONE. 7(7). e40431–e40431. 31 indexed citations
12.
13.
Gückenberger, Matthias, et al.. (2011). Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. Strahlentherapie und Onkologie. 187(9). 548–554. 16 indexed citations
14.
Gentner, R., et al.. (2010). Encoding of Motor Skill in the Corticomuscular System of Musicians. Current Biology. 20(20). 1869–1874. 87 indexed citations
15.
Melzer, Nico, Joseph Claßen, Karlheinz Reiners, & Mathias Buttmann. (2010). Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q. Journal of the Neurological Sciences. 296(1-2). 104–106. 5 indexed citations
16.
Buttmann, Mathias. (2010). Treating multiple sclerosis with monoclonal antibodies: a 2010 update. Expert Review of Neurotherapeutics. 10(5). 791–809. 32 indexed citations
17.
Haarmann, Axel, Jürgen H. Prochaska, Christian Foerch, et al.. (2010). Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown. PLoS ONE. 5(10). e13568–e13568. 37 indexed citations
18.
Dombrowski, Yvonne, Cathrin Ritter, Mathias Buttmann, et al.. (2009). Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells. Cancer Research. 69(20). 8058–8066. 101 indexed citations
19.
Hofstetter, Harald H., Mathias Buttmann, Thomas G. Forsthuber, et al.. (2007). The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. Cytokine. 40(1). 35–43. 24 indexed citations
20.
Buttmann, Mathias, et al.. (2007). Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. Journal of Neurochemistry. 102(4). 1001–1008. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.‐P. Hartung Breakdown of academic impact, for papers by Camelia‐Maria Monoranu Breakdown of academic impact, for papers by Alastair Compston Breakdown of academic impact, for papers by Ian Sutton Breakdown of academic impact, for papers by Peter J. Darlington Breakdown of academic impact, for papers by Tomoko Okamoto Breakdown of academic impact, for papers by Christopher Harp Breakdown of academic impact, for papers by Tatsusada Okuno Breakdown of academic impact, for papers by Merja Soilu‐Hänninen Breakdown of academic impact, for papers by Maddalena Ruggieri
Rankless by CCL
2026